Real-time enrollment status for this cervical intraepithelial neoplasia grade 2/3 clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:57 AM UTC
| NCT Number | NCT07454915 |
| Recruiting Status | Recruiting |
| Condition | Cervical Intraepithelial Neoplasia Grade 2/3 |
| Phase | PHASE2 |
| Target Enrollment | 138 participants |
| Active Locations | 1 sites in the US |
| Sponsor | PapiVax Biotech, Inc. |
| Last Updated on CT.gov | May 6, 2026 (May 6, 2026) |
As of August 30, 2026: Clinical trial NCT07454915 is currently recruiting participants. This phase2 study for cervical intraepithelial neoplasia grade 2/3 is actively seeking new participants at 1 location across the United States. The study is sponsored by PapiVax Biotech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07454915 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07454915 was last updated May 6, 2026 (May 6, 2026). HelloStudys verifies this status automatically.